2020 puberty-blocking drug restriction at London's gender identity clinic did not significantly increase suicides, according to independent review.
Professor Louis Appleby's independent review found no significant increase in suicides among young patients attending a gender identity clinic in London following the restriction of puberty-blocking drugs in 2020. The review, commissioned by Health Secretary Wes Streeting, analyzed data from NHS England, debunking claims by campaigners suggesting an increase in suicide rates due to the restricted use of the drugs at the Tavistock and Portman NHS Trust. Professor Appleby emphasized the importance of handling public discussions surrounding the issue responsibly, due to the potential impact on distressed adolescents.
July 19, 2024
13 Articles